Albumins

You have accessRestricted Access
Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease
Johannes F.E. Mann, Vivian A. Fonseca, Neil R. Poulter, Itamar Raz, Thomas Idorn, Søren Rasmussen, Bernt Johan von Scholten, Ofri Mosenzon and on behalf of the LEADER Trial Investigators

CJASN April 2020, 15 (4) 465-473; DOI: https://doi.org/10.2215/CJN.11881019

Add to Selected Citations
You have accessRestricted Access
Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD
Stanford E. Mwasongwe, Rikki M. Tanner, Bharat Poudel, Daniel N. Pugliese, Bessie A. Young, Marwah Abdalla, Solomon K. Musani, Orlando M. Gutiérrez, Adolfo Correa, Daichi Shimbo and Paul Muntner

CJASN April 2020, 15 (4) 501-510; DOI: https://doi.org/10.2215/CJN.08840719

Add to Selected Citations
Open Access
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin and Eugene P. Rhee

CJASN March 2020, 15 (3) 404-411; DOI: https://doi.org/10.2215/CJN.07420619

Add to Selected Citations
You have accessRestricted Access
Screening for CKD To Improve Processes of Care among Nondiabetic Veterans with Hypertension
Carmen A. Peralta, Martin Frigaard, Leticia Rolon, Karen Seal, Delphine Tuot, Josh Senyak, Lowell Lo, Neil Powe, Rebecca Scherzer, Shirley Chao, Phillip Chiao, Kimberly Lui, Michael G. Shlipak and Anna D. Rubinsky

CJASN February 2020, 15 (2) 174-181; DOI: https://doi.org/10.2215/CJN.05050419

Add to Selected Citations
You have accessRestricted Access
Sodium Bicarbonate Supplementation and Urinary TGF-β1 in Nonacidotic Diabetic Kidney Disease
Kalani L. Raphael, Tom Greene, Guo Wei, Tristin Bullshoe, Kunani Tuttle, Alfred K. Cheung and Srinivasan Beddhu

CJASN February 2020, 15 (2) 200-208; DOI: https://doi.org/10.2215/CJN.06600619

Add to Selected Citations
You have accessRestricted Access
Development and Validation of a Pragmatic Electronic Phenotype for CKD
Jenna M. Norton, Kaltun Ali, Claudine T. Jurkovitz, Krzysztof Kiryluk, Meyeon Park, Kensaku Kawamoto, Ning Shang, Sankar D. Navaneethan, Andrew S. Narva and Paul Drawz

CJASN September 2019, 14 (9) 1306-1314; DOI: https://doi.org/10.2215/CJN.00360119

Add to Selected Citations
Open Access
Effects of Treatment of Metabolic Acidosis in CKD
Sankar D. Navaneethan, Jun Shao, Jerry Buysse and David A. Bushinsky

CJASN July 2019, 14 (7) 1011-1020; DOI: https://doi.org/10.2215/CJN.13091118

Add to Selected Citations
You have accessRestricted Access
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
Toshiaki Ohkuma, Min Jun, John Chalmers, Mark E. Cooper, Pavel Hamet, Stephen Harrap, Sophia Zoungas, Vlado Perkovic, Mark Woodward and on behalf of the ADVANCE Collaborative Group

CJASN June 2019, 14 (6) 862-872; DOI: https://doi.org/10.2215/CJN.13391118

Add to Selected Citations
You have accessRestricted Access
Hepatorenal Syndrome
Claire Francoz, François Durand, Jeffrey A. Kahn, Yuri S. Genyk and Mitra K. Nadim

CJASN May 2019, 14 (5) 774-781; DOI: https://doi.org/10.2215/CJN.12451018

Add to Selected Citations
Open Access
Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria
Sadayoshi Ito, Tomoya Kagawa, Takuya Saiki, Kohei Shimizu, Shingo Kuroda, Yuhei Sano and Yuusuke Umeda

CJASN March 2019, 14 (3) 354-363; DOI: https://doi.org/10.2215/CJN.07720618

Add to Selected Citations

Main menu

User menu

Search

Albumins

Pages

About

Author Information

More information